title: Four years' experience with cyclosporine A in pediatric kidney transplantation.
authors.affiliation: Department of Pediatric Nephrology and Metabolic Disorders, Medical School Hannover, FRG.
authors.forename: P F
authors.initials: PF
authors.lastname: Hoyer
authors.forename: G
authors.initials: G
authors.lastname: Offner
authors.forename: B S
authors.initials: BS
authors.lastname: Oemar
authors.forename: J
authors.initials: J
authors.lastname: Brodehl
authors.forename: B
authors.initials: B
authors.lastname: Ringe
authors.forename: R
authors.initials: R
authors.lastname: Pichlmayr
mesh_terms: D002648:Child; D003524:Cyclosporins / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate; D006085:Graft Survival; D006130:Growth Disorders / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D008297:Male; D008657:Metabolic Clearance Rate; D011239:Prednisolone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
chemical_list: D003524:Cyclosporins; D014527:Uric Acid; D011239:Prednisolone